At Mustang Creek Estates, we are committed to providing personalized, high-quality care that supports the health, comfort, and well-being of every resident. We are excited to announce that we now offer Pharmacogenomics (PGx) Testing through GeneID, an innovative service that helps healthcare providers make more informed medication decisions based on an individual's unique genetic profile.
What is PGx Testing?
Pharmacogenomics (PGx) testing uses a simple cheek swab to analyze how a person's genes may influence their response to medications. This information can help providers identify medications and dosages that are more likely to be effective while reducing the risk of unwanted side effects.
Benefits of GeneID PGx Testing
Personalized Medication Plans – Tailors medication choices to each resident's genetic makeup.
Reduces Trial and Error – Helps eliminate guesswork when finding the most effective medications and dosages.
Improves Quality of Life – Supports better outcomes with fewer medication-related challenges.
Especially Beneficial for Cognitive and Behavioral Health Needs – May help guide treatment decisions for residents experiencing dementia, anxiety, depression, and other behavioral or psychological concerns.
One-Time Test, Lifelong Value – Results can be used throughout a resident's life to help guide future medication decisions.
Advancing Personalized Care
By offering GeneID PGx testing, Mustang Creek Estates continues to invest in innovative solutions that enhance resident care and provide peace of mind for families. This advanced approach supports our mission of delivering individualized care that promotes better health outcomes and improved quality of life.
If you would like to learn more about GeneID PGx testing or find out whether this service may be beneficial for you or your loved one, please contact your local Mustang Creek Estates community.
June 17, 2026